Abstract
Purpose: In China the number of pathologists is far from being enough to meet the demands of ongoing population based cervical cancer screening programs. This article aims to present our experience with automated quantitative cytology imaging platform, a reading system with an artificial intelligence that we currently use routinely for cervical cancer screening in Shanxi province.Methods: From 2012-2016 a total of 40 178 women were screened. Women were divided into three groups and each group had two subgroups. Smear and liquid based technique were compared using manual and automated platform.Results: Detection rates of CIN2 + and positive rates of CIN2 were higher in all three groups when automated quantitative cytology platform was used compared with groups where reading was done by the pathologist using conventional microscope. Operator’s costs associated with automated quantitative cytology platform vs. conventional reading using light microscope were compared too. The overall costs of operations based on automated platform were proven to be lower.Conclusion: The use of automated platform and artificial intelligence as a means to overcome the lack of cytotechnologists and pathologists and to implement proper quality control in the large scale population based cervical cancer screening seems very promising.
Highlights
According to the WHO / IARC (World Health Organization / International Agency for Cancer Research) data from 2012 showed that cervical cancer is the fourth most frequent malignant tumor in women
The use of automated platform and artificial intelligence as a means to overcome the lack of cytotechnologists and pathologists and to implement proper quality control in the large scale population based cervical cancer screening seems very promising
Out of that number about 85% of cervical cancer occurred in the developing countries, accounting for 12.0% of all female malignancies, while cervical cancer in developed countries accounted for only 3.0%
Summary
According to the WHO / IARC (World Health Organization / International Agency for Cancer Research) data from 2012 showed that cervical cancer is the fourth most frequent malignant tumor in women. The same report shows that the global annual incidence of cervical cancer was 528 000 with estimated 266 000 deaths in the same year. The average age-standardized mortality rate for cervical cancer in developing countries was 8.3 per 100 000, while in developed countries that number is lower, at 3.3 per 100 000. In China, cervical cancer is known to be one of the major malignant tumors that affects women’s health and life. Peking University Health Care Center (2016) published that after 2000, the incidence of cervical cancer in China is on the rise while the mortality rate stayed somewhat the same. Exploring a simple and efficient screening method for cervical cancer that can be applied to http://cco.ccsenet.org
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
